Stanford University


Showing 1,291-1,300 of 1,538 Results

  • Victoria "Vicki" Spencer

    Victoria "Vicki" Spencer

    Adm Assoc 4, Pediatrics - Peds/Critical Care

    BioA graduate of Purdue University, Vicki brings over 20 years of executive administrative support experience to her position at Stanford Medicine.

    Prior to taking this role, Vicki supported the Chief Medical Officer and Chief Dental Officer for a group of Federally Qualified Health Centers (FQHC). She has also provided executive support to individuals in the field(s) of healthcare, food equity, and pre-clinical drug development.

    Her passions are health equity and whole-system integrated care.

  • Chelse Spinner, PhD, MPH

    Chelse Spinner, PhD, MPH

    Postdoctoral Scholar, Neonatal and Developmental Medicine

    BioAn Ohio native, Dr. Chelse Spinner obtained a Bachelor of Science in Biological Sciences (Biomedical Studies) with a minor in Health Education from the University of Cincinnati. She earned a Master of Public Health in Epidemiology and Maternal & Child Health (MCH) from the University of South Florida. She received a Doctor of Philosophy in Public Health Sciences with a concentration in Behavioral Sciences from the University of North Carolina at Charlotte. Dr. Spinner is certified in public health and has experience working across health systems. Her research interests include health disparities, women’s health, social determinants of health, domains of structural racism, and oral-systemic health within the MCH population. She employs quantitative and qualitative methods in the hopes of providing innovative and evidence-informed research to improve health outcomes for marginalized and underserved communities. Her research agenda intends to focus on the exploration of social and structural factors that impact health and well-being.

  • Diane Stafford

    Diane Stafford

    Clinical Professor, Pediatrics - Endocrinology

    BioDr. Stafford specializes in Pediatric Endocrinology with special interest in disorders of puberty and Prader-Willi syndrome (PWS). Her research interests include in medical education curriculum development, faculty development and endocrine dysfunction in PWS.

  • Katherine Steffen

    Katherine Steffen

    Clinical Professor, Pediatrics - Critical Care

    Current Research and Scholarly InterestsMy research interests focus on using dissemination and implementation science tools to study and enhance care provided to patients in the pediatric ICU. I have a background in human factors research and in implementation science and am also interested in clinical effectiveness and outcomes in the PICU.

  • Lea Steffes

    Lea Steffes

    Assistant Professor of Pediatrics (Pulmonary Medicine)

    BioDr. Steffes is a pediatric pulmonologist and Assistant Professor in Pediatrics in the Division of Pulmonary Medicine at Stanford University. She has completed an advanced fellowship in Pulmonary Vascular Disease at Lucile Packard Children's Hospital Stanford. Her clinical expertise focuses on rare pediatric lung diseases, with particular specialization in heritable forms of pulmonary vascular disease and developmental lung disorders.
    Dr. Steffes' research centers on understanding the cellular characteristics of occlusive neointimal lesions, the abnormal cells that obstruct pulmonary blood flow in pulmonary hypertension. Her work specifically examines the contribution of mesenchymal cell subsets to pediatric pulmonary vascular disease, delineating mechanisms within both pre- and post-capillary networks. By leveraging insights from developing human and diseased mouse lung, her research provides a mechanistic framework for understanding childhood-onset pulmonary vascular diseases with the ultimate goal of identifying novel therapeutic targets for pulmonary hypertension.

  • Lawrence Steinman, MD

    Lawrence Steinman, MD

    George A. Zimmermann Professor and Professor of Pediatrics

    Current Research and Scholarly InterestsOur laboratory is dedicated to understanding the pathogenesis of autoimmune diseases, particularly multiple sclerosis. We have developed several new therapies for autoimmunity, including some in Phase 2 clinical trials, as well as one approved drug, natalizumab. We have developed microarray technology for detecting autoantibodies to myelin proteins and lipids. We employ a diverse range of molecular and celluar approaches to trying to understand multiple sclerosis.